Literature DB >> 19441002

Total syntheses of a conformationally locked North-type methanocarba puromycin analogue and a dinucleotide derivative.

Benoît Y Michel1, Peter Strazewski.   

Abstract

An original synthetic approach for the first synthesis of an enantiopure methanocarba puromycin (3'-alpha-aminoacylamino-3'-deoxyadenosine) analogue and its cytidine dinucleotide derivative is described. Each compound is conformationally locked in a North-type pucker and exhibits both a pseudoaxial hydroxy group and a pseudoequatorial aminoacyl group. The syntheses were accomplished from D-ribose in 18 and 19 steps, respectively, with key steps being a ring-closing metathesis, a Luche reduction, a Simmons-Smith cyclopropanation, a Mitsunobu coupling, a Mattocks bromoacetylation, a regioselective and a stereoselective nucleophilic substitution, a chemoselective phosphoramidite coupling and a Staudinger-Vilarrasa coupling. Both molecules are being tested for peptidyl transfer efficiency in ribosomes for comparison with the peptidyl transfer kinetics of natural puromycin and other natural and synthetic ribosomal A site substrates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19441002     DOI: 10.1002/chem.200802629

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Methanocarba ring as a ribose modification in ligands of G protein-coupled purine and pyrimidine receptors: synthetic approaches.

Authors:  Dilip K Tosh; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2013-12-17       Impact factor: 3.597

Review 2.  Polypharmacology of conformationally locked methanocarba nucleosides.

Authors:  Kenneth A Jacobson; Dilip K Tosh; Kiran S Toti; Antonella Ciancetta
Journal:  Drug Discov Today       Date:  2017-08-03       Impact factor: 7.851

3.  Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain.

Authors:  Dilip K Tosh; Janak Padia; Daniela Salvemini; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2015-06-27       Impact factor: 3.765

4.  Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure-Affinity Relationships.

Authors:  Jan Phillip Lemmerhirt; Andreas Isaak; Rongfang Liu; Max Kock; Constantin G Daniliuc; Kenneth A Jacobson; Laura H Heitman; Anna Junker
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

Review 5.  Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.

Authors:  Kenneth A Jacobson; Veronica Salmaso; R Rama Suresh; Dilip K Tosh
Journal:  RSC Med Chem       Date:  2021-07-13

6.  Efficient access to N-trifluoroacetylated 2'-amino-2'-deoxyadenosine phosphoramidite for RNA solid-phase synthesis.

Authors:  Christoph Falschlunger; Ronald Micura
Journal:  Monatsh Chem       Date:  2019-04-29       Impact factor: 1.451

7.  Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists.

Authors:  R Rama Suresh; Russell B Poe; Baorui Lin; Kexin Lv; Ryan G Campbell; Zhan-Guo Gao; Theodore E Liston; Kiran S Toti; Kenneth A Jacobson
Journal:  RSC Adv       Date:  2021-08-11       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.